Tighe Reardon, Acting Chief Financial Officer at Thoratec Corp, holds 4.15M shares in Janux Therapeutics Inc (Ticker: JANX), holds 0.00 shares in Synthorx (Ticker: THOR), holds 1.73M shares in Thoratec Corp (Ticker: ~THOR). Most recently, Tighe Reardon Sold ― shares of Janux Therapeutics Inc on Jun 05, 2024 for an estimated value of 45.04M.
What is the percentage of profitable transactions made by Tighe Reardon?
The percentage of profitable transactions made by Tighe Reardon is 67%.
What is the average return per transaction made by Tighe Reardon?
The average return per transaction made by Tighe Reardon is 132.70%.
What stocks does Tighe Reardon hold?
Tighe Reardon holds: ~THOR, THOR, JANX stocks.
What was Tighe Reardon’s latest transaction?
Tighe Reardon latest transaction was an Informative Sell of $45.04M.
What was Tighe Reardon's most profitable transaction?
Tighe Reardon’s most profitable transaction was an Informative Buy of JANX stock on November 15, 2023. The return on the trade was 432.60%.
What is Tighe Reardon's role in Thoratec Corp?
Tighe Reardon's role in Thoratec Corp is Acting Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.